A licence defines an authorised use

The MHRA’s authorisation concerns whether a particular medicine may be used for specified indications under its product information. It does not give every person with that condition an NHS prescription. A clinician still has to assess the individual.

A private price list answers a different question: what a provider publishes as its charge. It does not show that a person meets the prescriber’s criteria or that public funding is available.

The UK has four NHS systems

England, Scotland, Wales and Northern Ireland do not have identical assessment and implementation routes. Within a system, access may also depend on local services, referral pathways and a phased rollout. Start with your own GP practice or local weight-management service.

When reading a news story, identify the nation, the date, the patient group and the service covered. “Available on the NHS” is incomplete without that context. The UK country guide links the relevant sources used for this site.

Care is wider than a medicine request

The NHS describes support that can include weight-management programmes, medicines and surgery, depending on clinical circumstances. A conversation about care can begin before you have chosen a particular product.

If you are considering private care while also receiving NHS care, ask how information will be shared, who monitors treatment and who handles ongoing questions. Do not assume that a private prescription automatically transfers into NHS funding.

Follow the evidence

Sources & further reading

These links support the information above; they do not imply endorsement of this website.

  1. NHS: overweight and obesity in adults
  2. MHRA: medicines and healthcare products regulatory agency
A note on this guide

Written for a UK audience by the Health Comparisons editorial team. This page is an information resource and has not been presented as a clinician’s personal recommendation. Discuss treatment decisions with your prescriber.

Read our editorial standards →